Levels of CC16 and other parameters in balf of control subjects and sarcoid patients classified according to the chest radiograph findings
| Controls | Sarcoid patients | p-Value# | ||
| Chest radiograph Stages | ||||
| 0–I | II–III | |||
| Subjects n | 7 | 43 | 28 | |
| CC16 mg·L−1 | 0.46±0.18 | 0.40±0.43 | 0.52±0.34 | 0.06 |
| Albumin mg·L−1 | 25.3±10.6 | 53.6±37.0 | 73.9±78.5 | 0.2 |
| RBP µg·L−1 | 23.2±12.1 | 52.5±67.2 | 100.6±126.1 | 0.053 |
| Lymphocytosis % | 8.3±5.3 | 25.4±11.7* | 26.5±12.4* | 0.0001 |
| CD4/ CD8 ratio | 0.8±0.2 | 5.6±4.9* | 4.4±6.7* | 0.004 |
| Macrophages % | 91.5±5.1 | 70.8±12.5* | 71.5±12.4* | 0.008 |
| Neutrophils % | 0.6±0.5 | 2.9±8.2 | 2.3±2.8 | 0.36 |
Values are given as arithmetic mean±sd
#: differences in bronchoalveolar lavage fluid levels between controls and sarcoid patients classified according to the chest radiograph stages were assessed by analysis of variance (ANOVA) followed by the Fisher's least significant multiple comparison test
*: p<0.05 compared to controls
RBP: retinol binding protein